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Abstract
Background: It has been shown previously that human monocytes fed with haemozoin (HZ) or trophozoite-
parasitized RBCs displayed increased matrix metalloproteinase-9 (MMP-9) enzyme activity and protein/mRNA
expression and increased TNF production, and showed higher matrix invasion ability. The present study utilized
the same experimental model to analyse the effect of phagocytosis of: HZ, delipidized HZ, beta-haematin (lipid-
free synthetic HZ) and trophozoites on production of IL-1beta and MMP-9 activity and expression. The second
aim was to find out which component of HZ was responsible for the effects.
Methods: Native HZ freshly isolated from Plasmodium falciparum (Palo Alto strain, Mycoplasma-free), delipidized
HZ, beta-haematin (lipid-free synthetic HZ), trophozoites and control meals such as opsonized non-parasitized
RBCs and inert latex particles, were fed to human monocytes. The production of IL-1beta by differently fed
monocytes, in presence or absence of specific MMP-9 inhibitor or anti-hIL-1beta antibodies, was quantified in
supernatants by ELISA. Expression of IL-1beta was analysed by quantitative real-time RT-PCR. MMP-9 activity and
protein expression were quantified by gelatin zymography and Western blotting.
Results: Monocytes fed with HZ or trophozoite-parasitized RBCs generated increased amounts of IL-1beta and
enhanced enzyme activity (in cell supernatants) and protein/mRNA expression (in cell lysates) of monocyte MMP-
9. The latter appears to be causally related to enhanced IL-1beta production, as enhancement of both expression
and enzyme activity were abrogated by anti-hIL-1beta Abs. Upregulation of IL-1beta and MMP-9 were absent in
monocytes fed with beta-haematin or delipidized HZ, indicating a role for HZ-attached or HZ-generated lipid
components. 15-HETE (15(S,R)-hydroxy-6,8,11,13-eicosatetraenoic acid) a potent lipoperoxidation derivative
generated by HZ from arachidonic acid via haem-catalysis was identified as one mediator possibly responsible for
increase of both IL-1beta production and MMP-9 activity.
Conclusion: Results indicate that specific lipoperoxide derivatives generated by HZ may play a role in modulating
production of IL-1beta and MMP-9 expression and activity in HZ/trophozoite-fed human monocytes. Results may
clarify aspects of cerebral malaria pathogenesis, since MMP-9, a metalloproteinase able to disrupt the basal lamina
is possibly involved in generation of hallmarks of cerebral malaria, such as blood-brain barrier endothelium
dysfunction, localized haemorrhages and extravasation of phagocytic cells and parasitized RBCs into brain tissues.
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Background
Phagocytosis of haemozoin (HZ, malarial pigment) or
HZ-containing trophozoites alters functionality of human
monocytes and macrophages. Monocyte ability to per-
form oxidative burst is compromised [1], bacterial killing
abolished [2], antigen presentation altered [3], and ability
to differentiate to functional dendritic cells disturbed [4].
Moreover, HZ-laden monocytes produce increased
amounts of peroxidation products of polyunsaturated
fatty acids (PUFAs) [5] and stimulate generation of several
cytokines, such as TNF, IL-1beta, MIP-1alpha and MIP-
1beta [6,7].
It has been shown [8] that HZ/trophozoite-fed human
monocytes produced increased amounts of TNF and
upregulated mRNA/protein expression and activity of
matrix metalloproteinase-9 (MMP-9), a proteolytic
enzyme which degrades matrix proteins [9,10] and sheds
TNF and IL-1beta from cell-bound precursors [11,12]. As
TNF induces the synthesis of MMP-9 [13], ingested HZ
was found to generate a TNF-driven positive feedback
loop enhancing production of TNF and activity of MMP-
9, both blocked by a specific inhibitor of MMP-9.
Here it is shown that HZ/trophozoite-fed human mono-
cytes generated increased amounts of IL-1beta and
enhanced expression and activity of MMP-9. The latter
appears to be causally related to enhanced IL-1beta pro-
duction, as both expression and activation were abrogated
by anti-hIL-1beta Abs. It is also shown that upregulation
of IL-1beta and MMP-9 was absent in monocytes fed with
beta-haematin (lipid-free synthetic HZ) or delipidized
HZ, indicating a role for HZ-generated lipid components.
15-HETE (15(S,R)-hydroxy-6,8,11,13-eicosatetraenoic
acid), a potent lipoperoxidation derivative generated by
HZ from arachidonic acid via haem-catalysis [5] was iden-
tified as one mediator possibly responsible for increased
IL-1beta production and MMP-9 activity.
Methods
Materials
All materials were from Sigma-Aldrich, St Louis, MO,
unless otherwise stated. Cell culture media RPMI 1640,
Macrophage-SFM medium, TRIzol, M-MLV, oligo-dT,
sense and anti-sense primers, Platinum Taq DNA
Polymerase were from Invitrogen, Carlsbad, CA; Panserin
601 monocyte medium was from PAN Biotech, Aiden-
bach, Germany; recombinant human (rh)IL-1beta, block-
ing anti-human (h)IL-1beta antibodies and Merck's
inhibitor I, (N-hydroxy-1-(4-methoxyphenyl)sulfonyl-4-
(4-biphenylcarbonyl)piperazine-2-carboxamide), a spe-
cific inhibitor of MMP-9/MMP-13 activity, were from
Merck, Darmstadt, Germany; ELISA kit for IL-1beta assay
and 15-HETE were from Cayman, Ann Arbor, MI; anti-D
IgG were from Immuno AG, Vienna, Austria; Percoll was
from Pharmacia, Uppsala, Sweden; Dynabeads M-450
CD2 Pan T and M-450 CD19 Pan B were from Dynal,
Oslo, Norway; Diff-Quik parasite stain was from Baxter
Dade AG, Dudingen, Switzerland; sterile plastics were
from Costar, Cambridge, UK; bicinchoninic acid protein
assay was from Pierce, Rockford, IL; anti-MMP-9 mono-
clonal antibodies were from Santa Cruz Biotechnology,
Santa Cruz, CA; DNA-free kit was from Ambion, Austin,
TX; Beacon Designer 2.1 software was from Premier Bio-
soft International, Palo Alto, CA; dNTPs were from
Applied Biosystem, Foster City, CA. 4-hydroxynonenal
(HNE) was from Biomol, Plymouth Meeting, PA. Beta-
haematin (synthetic HZ) was prepared according to the
Slater et al [14] procedure, modified as indicated [15].
Cultivation of Plasmodium falciparum and isolation of 
trophozoite-parasitized RBCs and native or delipidized HZ
Plasmodium falciparum parasites (Palo Alto strain, Myco-
plasma-free) were kept in culture as described [4]. HZ and
trophozoite-parasitized RBCs (trophozoites) isolated
from cultures during the first two days after infection of
RBCs were added to schizonts (multinucleated parasite
form). After centrifugation at 5,000 g on a discontinuous
Percoll-mannitol density gradient, native HZ was col-
lected from the 0–40% interphase and trophozoites/sch-
izonts from the 40–80% interphase [4]. Native HZ was
washed five times with 10 mM HEPES (pH 8.0) contain-
ing 10 mM mannitol at 4°C and once with PBS, and
stored at 20% (vol/vol) in PBS at -20°C. For delipidized
haemozoin, lipid extraction was performed as previously
reported [5]. After isolation, HZ and trophozoites
enriched to 95–97% parasitaemia were washed twice and
reincubated in RPMI 1640 for 1 h at 37°C before opsoni-
zation and phagocytosis.
Preparation and handling of monocytes
Human monocytes were separated by Ficoll centrifuga-
tion from freshly collected buffy coats discarded from
blood donations by healthy adult donors of both sexes
provided by the local blood bank (AVIS, Associazione
Volontari Italiani Sangue, Torino, Italy) [1]. Separated
lymphomonocytes were resuspended in RPMI 1640
medium and plated on wells of six-well plates. Each well
received 2 ml of cell suspension containing 8 × 106 cells/
ml in RPMI 1640. The plates were incubated in a humidi-
fied CO2/air-incubator at 37°C for 60 min. Thereafter,
non-adherent cells were removed by three washes with
RPMI 1640 and adherent cells reincubated at 37°C over-
night in RPMI 1640. Shortly before starting phagocytosis,
wells were washed with RPMI 1640 and Macrophage-SFM
medium added (2 ml/well). Adherent cells prepared by
this method were detached from the plates by scraping,
stained with specific antibodies and analysed on a FACS-
can flow cytometer (Becton-Dickinson, San Jose, CA). As
an average, monocytes (CD14+ cells) were 63.8 ± 5.7%,Malaria Journal 2008, 7:157 http://www.malariajournal.com/content/7/1/157
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lymphocytes 36.2 ± 5.7% (mean values ± SD, n = 6) of all
mononuclear cells. For selected experiments, lympho-
monocytes were separated by Ficoll centrifugation from
fresh buffy coats (see above) and monocytes immunopu-
rified by depletion of non-monocytic cells from lympho-
monocytes. Dynabeads M-450 CD2 Pan T and M-450
CD19 Pan B (Dynal) were added to the lymphomono-
cytes in a 2:1 ratio for 20 min at 4°C. B and T lymphocytes
were removed by biomagnetic separation as specified by
the manufacturer. The remaining monocytes were washed
twice and resuspended in Macrophage-SFM medium. By
this method monocytes (CD14+ cells) were 73.6 ± 9.5%
pure, (mean values ± SD, n = 6, range 62–89.2%).
Phagocytosis by adherent monocytes of opsonized 
trophozoites, native or delipidized HZ, beta-haematin, 
nonparasitized opsonized RBCs and latex particles
To each well of a six-well plate with approx. 1 × 106 adher-
ent monocytes, 50 μl trophozoites (10% haematocrit),
native or delipidized HZ (120 nmoles HZ haem, an
amount comparable to 50 μl trophozoites on haem con-
tent basis), 50 μl beta-haematin (120 nmoles haem), 50
μl anti-D IgG-opsonized RBCs (10% haematocrit) and 50
μl amine-modified, red-fluorescent latex particles (2.5%
solids, diameter 0.105 μm) were added. Trophozoites,
native and delipidized HZ, beta-haematin and latex parti-
cles were opsonized with fresh autologous serum, and
nonparasitized RBCs were opsonized with anti-D IgG as
indicated [1,5]. After opsonization, all phagocytic meals
were suspended in Macrophage-SFM medium. The plates
were centrifuged at low speed for 5 seconds to start phago-
cytosis and incubated in a humidified CO2/air-incubator
at 37°C for 3 hours. This time period maximized phago-
cytosis and was not sufficient to induce haem-oxygenase-
mediated degradation of ingested haem [16]. Thereafter,
non-ingested cells, HZ, latex and beta-haematin particles
were removed by four washes with RPMI 1640. The plates
were then incubated in a humidified CO2/air-incubator at
37°C for the indicated times. In selected experiments,
cells were incubated with rhIL-1beta (20 ng/ml), blocking
anti-hIL-1beta antibodies (30 ng/ml) or Merck's inhibitor
I, a specific inhibitor of MMP-9/MMP-13 activity (4 ng/
ml) for 48 h.
Assay of IL-1beta production
After termination of phagocytosis, monocytes were fur-
ther incubated with Panserin 601 monocyte medium in a
humidified CO2/air-incubator at 37°C for 48 h in pres-
ence (4 ng/ml) or absence of Merck's inhibitor I, a specific
inhibitor of MMP-9/MMP-13 activity. The level of active
soluble IL-1beta was assayed in monocyte supernatants by
ELISA. A standard calibration curve was generated with
rhIL-1beta, according to the manufacturer's instructions.
Assay of MMP-9 activity by gelatin zymography
After termination of phagocytosis, monocytes were fur-
ther incubated with Panserin 601 monocyte medium in a
humidified CO2/air-incubator at 37°C for 48 h. Thereaf-
ter, the activity of MMP-9 was evaluated by gelatin zymog-
raphy in the cell supernatants as indicated [8,17,18].
Supernatants were loaded on 8% polyacrylamide gels
containing 0.1% gelatin under non-denaturing and non-
reducing conditions. Following electrophoresis, gels were
washed and incubated for 18 h at 37°C in a collagenase
buffer. Densitometric analysis of the bands considered to
reflect total enzymatic activity of MMP-9, was performed
using a computerized densitometer (Chemidoc, Biorad,
Hercules, CA) with activity presented in relative units
compared to background.
Assay of MMP-9 protein expression by western blotting
After termination of phagocytosis, monocytes were fur-
ther incubated with Panserin 601 monocyte medium in a
humidified CO2/air-incubator at 37°C for 48 h. Thereaf-
ter, cells were washed and lysed at 4°C in lysis buffer con-
taining (mM): NaCl, 300; Tris, 50; 1% (vol/vol) Triton-
X100; protease and phosphatase inhibitors: pepstatin, 50
ng/ml; leupeptin, 50 ng/ml; aprotinin, 10 μg/ml. The pro-
tein content in the lysate was measured by the bicin-
choninic acid assay and 12 μg protein/lane were added to
the loading buffer. The lysates samples were loaded on 8%
polyacrylamide gels under denaturing and reducing con-
ditions, with addition of Laemmli buffer, blotted on a
polyvinylidene difluoride membrane, and probed with
anti-MMP-9 monoclonal antibodies at 1/1,000 final dilu-
tion. Bands were visualized by enhanced chemilumines-
cence. Densitometric analysis of the bands was performed
using a computerized densitometer (Chemidoc).
Assay of IL-1beta mRNA expression by real-time 
quantitative RT-PCR
After termination of phagocytosis, monocytes were fur-
ther incubated with Panserin 601 monocyte medium in a
humidified CO2/air-incubator at 37°C for 6 h (immu-
nopurified monocytes) or 15 h (adherent monocytes).
Total cellular RNA from 2 × 106 cells was isolated from
monocytes by TRIzol, according to the manufacturer's
instructions, and eluted in 20 μl diethyl pyrocarbonate
water. To remove any contaminating DNA, RNA was
treated with Ambion's DNA-free kit (Ambion). Retrotran-
scription was performed using 6 μg of RNA, 200 U/μl of
M-MLV and 25 μ/μl oligo-dT (Invitrogen). Real-time
quantitative RT-PCR was performed with the iCycler
instrument (Bio-Rad) and data analysis was performed
with iCycler iQ Real-Time Detection System Software ver-
sion 3.0 (Bio-Rad). IL-1beta (GenBank accession no.
NM_000576) oligonucleotide sequences (forward: 5'-
ACA GAT GAA GTG CTC CTT CCA-3', reverse: 5'-GTC
GGA GAT TCG TAG CTG GAT-3') were identified usingMalaria Journal 2008, 7:157 http://www.malariajournal.com/content/7/1/157
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Beacon Designer Software package and designed to be
intron-spanning allowing the differentiation between
cDNA and DNA-derived PCR products. PCR amplification
was carried out in 25 μl of reaction mixture. 1 μl of cDNA
(corresponding to 105 cells) and 400 nM primers were
added to the amplification mixture (iQ SYBR Green
Supermix, Bio-Rad). DNA polymerase was pre-activated
for 2 min at 94°C, and the amplification was performed
by a 40-cycle PCR (94°C, 30 s, 60°C, 30 s and 72°C, 30
s). Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was used as reference gene to normalize cDNA
across samples. Relative quantitation for IL-1 beta,
expressed as -fold variation over untreated control cells,
was calculated using the 2-ΔΔCT method. To validate the
use of the 2-ΔΔCT method, serial dilutions of cDNA from
monocytes stimulated for 6 or 15 h by 20 ng/ml rhTNF,
were tested. Analysed transcripts exhibited high linearity
amplification plots (r > 0.98) and similar PCR efficiency
(85.7% for IL-1 beta and 86.5% for GAPDH), confirming
that the expression of each gene could be directly com-
pared. The specificity of PCRs was confirmed by melt
curve analysis. Values are means of triplicate measure-
ments.
Results
Enhancement of IL-1beta production by adherent 
monocytes fed with HZ or trophozoites
Adherent monocytes were allowed to phagocytose HZ,
trophozoites, nonparasitized opsonized RBCs and latex
particles (control meals) during 3 h. As an average, each
monocyte ingested 8–10 trophozoites, or HZ equivalent
to 8–10 trophozoites in terms of ingested haem, or almost
8–10 non-parasitized anti-D IgG opsonized RBCs, as
shown previously [1,19]. After termination of phagocyto-
sis and elimination of noningested phagocytic meals by
repeated washings, and further incubation during 48 h,
IL-1beta production was measured by ELISA in cell super-
natants. Compared to unfed control monocytes, IL-1beta
production was increased approximately two-fold after
phagocytosis of HZ or trophozoites, whereas phagocytosis
of control meals did not affect significantly cytokine pro-
duction (Figure 1). In selected experiments, adherent
monocytes after the 3 h phagocytic period were further
incubated for 48 h in presence of Merck's inhibitor I, a
specific inhibitor of MMP-9/MMP-13 activity. Supple-
mentation of this inhibitor did not affect cytokine produc-
tion by HZ/trophozoite-fed monocytes.
Enhancement of MMP-9 protein expression and enzyme 
activity in adherent monocytes after HZ phagocytosis and 
rhIL-1beta treatment. Abrogation of the HZ effect by anti-
hIL-1beta antibodies
Unfed, latex-fed and HZ-fed adherent monocytes after ter-
mination of phagocytosis were further incubated for 15 h
(MMP-9 mRNA expression studies) or 48 h (MMP-9 activ-
ity and protein expression studies) in presence or absence
of 20 ng/ml rhIL-1beta and 30 ng/ml blocking anti-hIL-
1beta antibodies. Phagocytosis of HZ enhanced enzyme
activity (measured in cell supernatants) and protein
expression (measured in cell lysates), confirming previous
data obtained by this group [8] (Figure 2, panel A). rhIL-
1beta added to unfed or latex-fed monocytes mimicked
the HZ effect at the protein expression/enzyme activity
level (Figure 2, panel A and panel B) and at the mRNA
expression level, and further enhanced enzyme activity
when added to HZ-fed monocytes (Figure 2, panel A).
Blocking anti-hIL-1beta antibodies abrogated the
enhancement of protein expression (Figure 2, panel A)
and enzyme activity (Figure 2, panel B), and also inhib-
ited enhancement of mRNA expression observed after HZ
phagocytosis.
Role of lipidic component of HZ in enhancement of IL-
1beta production and MMP-9 activity in adherent 
monocytes after phagocytosis of HZ
Previous work has shown that PUFAs stably adherent to
the crystalline poly-haem core of native HZ are trans-
formed by non-enzymatic haem catalysis into a number
HZ and trophozoite phagocytosis enhances IL1-beta produc- tion by human adherent monocytes Figure 1
HZ and trophozoite phagocytosis enhances IL1-beta 
production by human adherent monocytes. Human 
adherent monocytes were unfed or fed with HZ, tropho-
zoites and control meals (IgG-anti D-opsonized nonparasit-
ized RBCs, latex particles). After 3 h phagocytosis and a 
further incubation during 48 h, IL1-beta levels were meas-
ured by ELISA in cell supernatants. Data are given as ng IL-
1beta/ml supernatant (mean values ± SD of six independent 
experiments). Data were analysed for significance by Stu-
dent's t-test. Significance of differences (column numbers): 
trophozoite-fed(3)/HZ-fed(5) vs unfed-(1)/nonparasitized 
RBC-fed(2) monocytes, p < 0.05; latex-fed(4) vs unfed-(1)/
nonparasitized RBC-fed(2) monocytes, n.s.; trophozoite-
fed(3) vs HZ-fed(5) monocytes, n.s.
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of potent lipoperoxidation derivatives [5]. To ascertain
whether lipids were involved in HZ-elicited activation of
MMP-9, lipid-free beta-haematin (synthetic HZ) and del-
ipidized native HZ were fed to adherent monocytes. After
phagocytosis, monocytes were further incubated for 48
hours and cell supernatants analysed by ELISA for IL-
1beta production and MMP-9 activity. Beta-haematin and
delipidized HZ were unable to enhance IL-1beta produc-
tion (Figure 3, panel A) and stimulate MMP-9 activity
(Figure 3, panel B).
Involvement of 15-HETE in HZ-mediated effects on IL-
1beta production and MMP-9 activity in adherent 
monocytes and on IL-1beta mRNA expression in 
immunopurified monocytes
Previous work has indicated that 15-HETE, a product of
arachidonic acid peroxidation by HZ, is an active media-
tor of HZ/trophozoite effects in monocytes [20]. As
shown in Figure 4, panel A, 15-HETE added to adherent
monocytes at 0.1–10 μM (final concentration) enhanced
production of IL-1beta, measured in cell supernatants 48
h after addition. 15-HETE added in the same concentra-
tion range also stimulated MMP-9 activity, similarly meas-
ured in cell supernatants 48 h after addition (Figure 4,
panel B). This second effect was not concentration-
dependent. Both 15-HETE-mediated effects were compa-
rable to those elicited by HZ/trophozoite phagocytosis. In
selected experiments with immunopurified monocytes,
IL-1beta mRNA expression measured 6 h after phagocyto-
HZ and trophozoite phagocytosis, and rhIL-1beta enhance MMP-9 protein expression (in cell lysates) and enzyme activity (in  cell supernatants) in human adherent monocytes Figure 2
HZ and trophozoite phagocytosis, and rhIL-1beta enhance MMP-9 protein expression (in cell lysates) and 
enzyme activity (in cell supernatants) in human adherent monocytes. Abrogation of the HZ effect by anti-hIL-
1beta antibodies. Human adherent monocytes were unfed, fed with HZ or latex particles treated or not with rhIL-1beta (20 
ng/ml) or blocking anti-hIL-1beta antibodies (30 ng/ml) as indicated. Panel A. Western blot with anti-MMP-9 antibodies and 
densitometric quantification of MMP-9 protein. After 3 h phagocytosis and a further incubation during 48 h, cell lysates were 
prepared, separated by PAGE (8% polyacrylamide) blotted and probed with anti-MMP-9 monoclonal antibodies (1/1000 final 
dilution). The 92-kDa band in the gel corresponds to pro-MMP-9. Data are given as arbitrary densitometric units (mean values 
± SD of four independent experiments). Panel B. Gelatin zymography and densitometric quantification of MMP-9 enzyme 
activity. After 3 h phagocytosis and a further incubation during 48 h, cell supernatants were separated by PAGE (8% polyacryla-
mide gel containing 0.1% gelatin) under non-denaturing and non-reducing conditions. The 83-kDa negative bands in the gel cor-
respond to MMP-9 enzyme activity. Data are given as arbitrary densitometric units (mean values ± SD of four independent 
experiments). Data (Panel A, Panel B) were analysed for significance by Student's t-test. Significance of differences (column/lane 
numbers): HZ-fed(7)/rhIL1beta(2)-stimulated vs control(1)/anti-hIL1beta-stimulated(3)/latex-fed(4) monocytes, p < 0.01 (Panel 
A) or p < 0.05 (Panel B). rhIL1beta-stimulated(2,5,8) vs HZ-fed(7,8) monocytes, n.s.; anti-hIL1beta-stimulated(3,6,9)/latex-
fed(4) vs unfed(1) monocytes, n.s.
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sis was increased 3,5-fold after HZ and 2-fold after addi-
tion of 10 μM 15-HETE (Figure 5). The stimulatory effect
of 15-HETE appears to be specific, as 4-hydroxynonenal
[4-HNE], another potent PUFA derivative generated by
HZ activity [21] was unable to stimulate IL-beta produc-
IL-1beta production and MMP-9 enzyme activity (in cell  supernatants) in human adherent monocytes unfed or fed  with HZ and treated or not with 15-HETE Figure 4
IL-1beta production and MMP-9 enzyme activity (in 
cell supernatants) in human adherent monocytes 
unfed or fed with HZ and treated or not with 15-
HETE. Human adherent monocytes were fed or not with 
HZ and treated or not with 15-HETE added at time 0 at 
0.1–10 μM (final concentration). Panel A. After 3 h phago-
cytosis and a further incubation during 48 h (HZ-fed mono-
cytes) or 48 h after addition of 15-HETE, IL-1beta levels 
were measured by ELISA in cell supernatants. Data are given 
as ng IL-1beta/ml supernatant (mean values ± SD of four 
independent experiments). Panel B. After 3 h phagocytosis 
and a further incubation during 48 h (HZ-fed monocytes) or 
48 h after addition of 15-HETE, cell supernatants were sepa-
rated by PAGE and MMP-9 enzyme activity measured by gel-
atin zymography and densitometric quantification (see legend 
to Figure 2 for details). The 83-kDa negative bands in the gel 
correspond to MMP-9 enzyme activity. Data are given as 
arbitrary densitometric units (mean values ± SD of four inde-
pendent experiments). Data were analysed for significance by 
Student's t-test. Significance of differences (column/lane num-
bers). Unfed(1) vs HZ-fed(5) monocytes, p < 0.05; unfed(1) 
vs 15-HETE-treated (3,4,5) monocytes, p < 0.05 (Panel A) 
and p < 0.01 (Panel B).
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IL-1beta production and MMP-9 enzyme activity (in cell  supernatants) in human adherent monocytes unfed or fed  with HZ, delipidized HZ or beta-haematin Figure 3
IL-1beta production and MMP-9 enzyme activity (in 
cell supernatants) in human adherent monocytes 
unfed or fed with HZ, delipidized HZ or beta-haema-
tin. Human adherent monocytes were unfed or fed with HZ, 
delipidized HZ (D-HZ) and beta-haematin. Panel A: IL-
1beta production. After 3 h phagocytosis and a further incu-
bation during 48 h, IL1-beta levels were measured by ELISA 
in cell supernatants. Data are given as ng IL-1beta/ml super-
natant (mean values ± SD of four independent experiments). 
Data were analysed for significance by Student's t-test and 
differences between delipidized HZ or beta-haematin against 
unfed controls were not significant. Panel B: Gelatin zymog-
raphy and densitometric quantification of MMP-9 enzyme 
activity. After 3 h phagocytosis and a further incubation dur-
ing 48 h, cell supernatants were separated by PAGE and 
MMP-9 enzyme activity measured by gelatin zymography and 
densitometric quantification (see legend to Figure 2 for 
details). The 83-kDa negative band in the gel corresponds to 
MMP-9 enzyme activity. Data are given as arbitrary densito-
metric units (mean values ± SD of four independent experi-
ments). Data (Panel A, panel B) were analysed for significance 
by Student's t-test. Significance of differences (column/lane 
numbers). HZ-fed(2) vs unfed(1)/D-HZ-(3)/beta-haema-
tin(4)-fed monocytes, p < 0.01; unfed(1) vs D-HZ(2)/beta-
haematin(4)-fed monocytes, n.s.
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tion and MMP-9 activity when added at 0.1 μM (final con-
centration) and downregulated both parameters when
added at 1–10 μM (final concentration).
Discussion
Matrix metalloproteinases (MMPs) are a family of zinc-
dependent enzymes characterized by their ability to
remodel/disrupt subendothelial matrix proteins and shed
or activate cytokines from their precursors [9-12,22].
MMPs play physiological roles, for example in wound
repair [22], and are also involved in pathological proc-
esses such as cancer metastasis [23] or neurological dis-
eases [24]. Basal transcription level of MMPs is generally
low [25], but it can be enhanced in various cell types
including monocytes, by cytokines and growth factors,
and by cell-cell or cell-matrix interactions [9]. Recently,
involvement of MMPs in malaria has been described. Dei-
ninger et al [26] found higher levels of MMP-1 and ang-
iogenic proteins such as VEGF in post-mortem samples of
brain tissues of patients dead from cerebral malaria. Van
den Steen et al [27] described higher MMP-9 expression in
brain and other tissues of mice with cerebral malaria. The
enzyme was apparently produced by cells of monocytic
lineage. Lastly, present group [8] has shown that human
adherent monocytes fed with HZ or HZ-containing tro-
phozoites displayed increased activity and mRNA/protein
expression of MMP-9, and increased production of TNF.
Since TNF induces expression of MMP-9, while MMP-9
sheds TNF from its membrane-bound precursor, interac-
tion between MMP-9 and TNF was considered to start a
positive feedback loop eventually enhancing the patho-
logical effects of both molecules: for MMP-9 – disruption
of subendothelial basal lamina and infiltration of mono-
nuclear cells in brain, lung and kidney – [28-30]; and for
TNF, – fever, hypoglycaemia, circulatory failure, and pla-
cental pathology – [31-35].
Present data show that IL-1beta production was enhanced
in HZ/trophozoite-fed adherent monocytes, and causally
related to enhancement of MMP-9 mRNA and protein
expression (measured in cell lysates) and MMP-9 enzyme
activity (measured in cell supernatants). Short-term exper-
iments were performed to establish which cytokine (TNF
or IL-1beta) was the primary target of HZ stimulatory
activity. Data indicate that while blocking anti-hIL-1beta
antibodies significantly reduced TNF production by HZ-
fed cells at 1 h (p < 0.05) and at 2 h (p < 0.02), blocking
anti-hTNF Abs did not affect the short-term production of
IL-1beta by HZ-fed cells. These data seem thus to suggest
that the enhancement of IL-1beta formation occurred first
followed by enhanced formation and activity of TNF and
MMP-9, respectively.
HZ and HZ-containing trophozoites contain large
amounts of monohydroxy derivatives of polyunsaturated
fatty acids (OH-PUFAs). OH-PUFAs are stable derivatives
of PUFA peroxidation, here most likely non-enzymati-
cally generated by haem-catalyzed lipid peroxidation car-
ried out by the poly-haem moiety of HZ [5]. High
concentration of HZ and acidic conditions are likely to
favour unspecific haem-catalyzed lipid peroxidation,
leading to a complex pattern of oxygenated products. Six
HETE isomers and two major isomers of HODE (hydrox-
yoctadeca-9Z,11E-dienoic acid, a linoleic acid derivative)
were found in HZ and trophozoites [5]. Of those mole-
cules and isomers, only 12- and 15-HETE mimicked toxic
effects of HZ/trophozoite phagocytosis in monocytes,
such as inhibition of oxidative burst and inhibition of dif-
ferentiation and maturation of monocytes to dendritic
cells [15]. HODE isomers were inactive. Native HZ was
found to contain 0.24 mmole 15-HETE/mole haem. 15-
HETE is further produced by ingested HZ, and HZ-fed
monocytes were found to shed 15-HETE into the superna-
tant and to contain approximately 10 μM 15-HETE, under
the realistic assumption of 10 RBC equivalents per mono-
cyte and a monocyte volume of 500 fL [5]. 4-HNE,
another PUFA derivative [21], supplemented here at 0.1
IL-1beta mRNA expression in immunopurified human adher- ent monocytes unfed or fed with HZ and treated or not with  15-HETE Figure 5
IL-1beta mRNA expression in immunopurified 
human adherent monocytes unfed or fed with HZ 
and treated or not with 15-HETE. Human CD14+ immu-
nopurified monocytes were unfed, fed with HZ or treated 
with 15-HETE added at time 0 at 1–10 μM (final concentra-
tion). 6 h after phagocytosis or addition of 15-HETE. mRNA 
expression was measured by real-time quantitative RT-PCR 
in cell lysates and expressed as -fold variation over untreated 
monocytes. Mean values ± SD of three independent experi-
ments. Data were analysed for significance by Student's t-
test. Significance of differences (column numbers). Unfed(1) 
vs HZ-fed(2) monocytes, p < 0.01; unfed(1) vs 15-HETE 1 
μM(3) treated monocytes, n.s.; unfed(1) vs 15-HETE 10 
μM(4) treated monocytes, p < 0.05.
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μM concentration did not stimulate IL-beta production or
MMP-9 activity, while it downregulated both parameters
at 1–10 μM concentration. Possible explanations may
reside in the strong reactivity of 4-HNE with thiols, such
as reduced glutathione, or amino-groups present in sus-
pending buffers. Additionally, 4-HNE tends to concen-
trate in the cell membrane where it generates adducts with
His and Cys residues of membrane proteins, possibly
interfering with the 15-HETE transduction pathway.
Based on present data, following sequence of events is
likely. First, 15-HETE, possibly together with co-gener-
ated, similarly active 12-HETE, would induce production
of IL-1beta and TNF via a yet undetermined transduction
pathway. It is likely that the NF-kB pathway is involved in
cytokine upregulation, as Jaramillo et al recently reported
activation of the NF-κB pathway in HZ-fed murine macro-
phages [36,37]. Subsequently, increased IL-1beta and TNF
would upregulate MMP-9 expression and activity. Indeed,
literature data indicate the NF-KB pathway as essential for
both TNF and IL-1beta induction, and the latter cytokines
as potent upregulators of MMP-9 [38,39].
Conclusion
Phagocytosis of HZ or trophozoite-parasitized RBCs was
shown to induce enhanced production of TNF and IL-
beta, and to increase mRNA and protein expression (both
measured in cell lysates), and enzymatic activity of MMP-
9 (measured in cell supernatants), a metalloproteinase
involved in disruption of basal membranes. Present data
indicate that lipid components attached to HZ were
instrumental for enhanced production of IL-1beta and
MMP-9 increase. In fact, the ability of HZ to non-enzy-
matically generate HETEs and the presence of HETEs in
HZ-fed monocytes [5], the lack of effects by feeding cells
with delipidated HZ, and the recapitulation of HZ effects
by supplementing exogeneous 15-HETE are converging
indications that 15-HETE, an active member of the HETE
family, may be causally involved in upregulation of IL1-
beta and MMP-9. Thus, HZ-derived 15-HETE might be a
molecule primarily responsible for cytokine induction
and MMPs activation and possibly instrumental in induc-
ing hallmarks of cerebral malaria such as localized haem-
orrhages and extravasation, migration and perivascular
accumulation of phagocytic cells. Interestingly, it was
recently shown that soluble factors released by tropho-
zoite-parasitized RBCs significantly decreased electrical
resistance of human brain-blood barrier endothelium,
indicating a parasite-mediated perturbation of the brain
monolayer barrier function [40].
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